Elamipretide (SS-31) Improves Functional Connectivity in Hippocampus and Other Related Regions Following Prolonged Neuroinflammation Induced by Lipopolysaccharide in Aged Rats
Neuroinflammation has been recognized as a major cause for neurocognitive diseases. Although the hippocampus has been considered an important region for cognitive dysfunction, the influence of hippocampal neuroinflammation on brain functional connectivity (FC) has been rarely studied. In this study,...
Main Authors: | Yang Liu, Huiqun Fu, Yan Wu, Binbin Nie, Fangyan Liu, Tianlong Wang, Wei Xiao, Shuyi Yang, Minhui Kan, Long Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2021.600484/full |
Similar Items
-
Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice
by: Weixing Zhao, et al.
Published: (2019-11-01) -
Elamipretide (SS-31) Ameliorates Isoflurane-Induced Long-Term Impairments of Mitochondrial Morphogenesis and Cognition in Developing Rats
by: Jian-Jun Yang, et al.
Published: (2017-04-01) -
Elamipretide Attenuates Pyroptosis and Perioperative Neurocognitive Disorders in Aged Mice
by: Youmei Zuo, et al.
Published: (2020-08-01) -
The effects of a mitochondrial targeted peptide (elamipretide/SS31) on BAX recruitment and activation during apoptosis
by: Joshua A. Grosser, et al.
Published: (2021-05-01) -
A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
by: Amel Karaa, et al.
Published: (2020-08-01)